Schiele, F., Mazighi, M., Danchin, N., Sibon, I., Lemesle, G., Mohammedi, K., . . . Massien, C. Cardiovascular risk associated with glucagon-like peptide-1 receptor agonists versus other conventional glucose-lowering drugs in patients with type-2 diabetes: Protocol for a nationwide observational comparative study in routine care. BMJ Publishing Group.
Chicago Style (17th ed.) CitationSchiele, François, et al. Cardiovascular Risk Associated with Glucagon-like Peptide-1 Receptor Agonists Versus Other Conventional Glucose-lowering Drugs in Patients with Type-2 Diabetes: Protocol for a Nationwide Observational Comparative Study in Routine Care. BMJ Publishing Group.
MLA (9th ed.) CitationSchiele, François, et al. Cardiovascular Risk Associated with Glucagon-like Peptide-1 Receptor Agonists Versus Other Conventional Glucose-lowering Drugs in Patients with Type-2 Diabetes: Protocol for a Nationwide Observational Comparative Study in Routine Care. BMJ Publishing Group.